When these so-called type X diabetics undergo bariatric surgery, the metabolic surgical effects predominate in minimizing the T2DM components of disease, although the patients still suffer from inherent type 1-type β-cell dysfunction and therefore require baseline insulin therapy. The gene discussed is INS; the disease is type 2 diabetes mellitus.